Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2004 Sep-Dec;12(3-4):115–120. doi: 10.1080/10647440400020687

Improving universal prenatal screening for human immunodeficiency virus.

Brenna L Anderson 1, Hyagriv N Simhan 1, Daniel V Landers 1
PMCID: PMC1784601  PMID: 15763910

Abstract

OBJECTIVE: To evaluate the effect of implementation of a human immunodeficiency virus (HIV) educational intervention on universal screening for HIV in a prenatal clinic setting. METHODS: In this retrospective cohort study, frequencies of offering and acceptance of HIV testing were compared before and after an educational intervention performed by an HIV-focused nurse. The records of 293 women seeking prenatal care before the intervention and 206 women seeking prenatal care after the intervention were reviewed for offering and acceptance of HIV testing. Fisher's exact test and logistic regression were used to evaluate the relationship between the educational intervention and the offering and acceptance of HIV testing. RESULTS: The frequency of HIV test offering at first visit and test acceptance before the educational intervention were 96.5% and 74.8%, respectively, and after the intervention were 99.5% and 84.3%, respectively. This improvement in offering (3% change) and acceptance (9.5% change) was statistically significant (offering at first visit: OR = 7.27, 95% CI = 1.02 to 316.9; test acceptance: OR = 1.82, 95% CI = 1.14 to 2.88). Test acceptance was statistically significantly improved in the post-intervention group after controlling for confounding variables (OR = 2.02, 95% CI = 1.2 to 3.39). CONCLUSION: The addition of an HIV-focused nurse to a clinic setting improved the frequency of test offering at first visit and of acceptance of HIV testing by pregnant women.

Full Text

The Full Text of this article is available as a PDF (75.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacci M., Repke J. T., Chaisson R. E. Routine prenatal screening for HIV infection. Lancet. 1991 Mar 23;337(8743):709–711. doi: 10.1016/0140-6736(91)90286-x. [DOI] [PubMed] [Google Scholar]
  2. Bulterys M. Preventing vertical HIV transmission in the year 2000: progress and prospects--a review. Placenta. 2001 Apr;22 (Suppl A):S5–S12. doi: 10.1053/plac.2001.0671. [DOI] [PubMed] [Google Scholar]
  3. Carneiro M., Sanchéz A., Maneiro P., Angelosante W., Pérez C., Valleé M. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up. Placenta. 2001 Apr;22 (Suppl A):S13–S18. doi: 10.1053/plac.2001.0670. [DOI] [PubMed] [Google Scholar]
  4. Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
  5. Cooper Ellen R., Charurat Manhattan, Mofenson Lynne, Hanson I. Celine, Pitt Jane, Diaz Clemente, Hayani Karen, Handelsman Edward, Smeriglio Vincent, Hoff Rodney. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484–494. doi: 10.1097/00126334-200204150-00009. [DOI] [PubMed] [Google Scholar]
  6. Foley E., Barton S. E., Harindra V., Hamer G., Mandalia S. Midwives and HIV antibody testing: identifying the key factors for achieving the targets. Int J STD AIDS. 2001 Nov;12(11):730–732. doi: 10.1258/0956462011924227. [DOI] [PubMed] [Google Scholar]
  7. Lansky A., Jones J. L., Frey R. L., Lindegren M. L. Trends in HIV testing among pregnant women: United States, 1994-1999. Am J Public Health. 2001 Aug;91(8):1291–1293. doi: 10.2105/ajph.91.8.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lindsay M. K. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening. Am J Obstet Gynecol. 1993 Feb;168(2):476–479. doi: 10.1016/0002-9378(93)90475-x. [DOI] [PubMed] [Google Scholar]
  9. McKinney M. M., McSpirit S., Pomeroy C. Prenatal HIV prevention practices in a low seroprevalence state. AIDS Educ Prev. 2000 Jun;12(3):252–262. [PubMed] [Google Scholar]
  10. Mercey D., Helps B. A., Copas A., Petruckevitch A., Johnson A. M., Spencer J. Voluntary universal antenatal HIV testing. Br J Obstet Gynaecol. 1996 Nov;103(11):1129–1133. doi: 10.1111/j.1471-0528.1996.tb09596.x. [DOI] [PubMed] [Google Scholar]
  11. Sperling R. S., Shapiro D. E., Coombs R. W., Todd J. A., Herman S. A., McSherry G. D., O'Sullivan M. J., Van Dyke R. B., Jimenez E., Rouzioux C. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996 Nov 28;335(22):1621–1629. doi: 10.1056/NEJM199611283352201. [DOI] [PubMed] [Google Scholar]
  12. Stringer E. M., Stringer J. S., Cliver S. P., Goldenberg R. L., Goepfert A. R. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol. 2001 Dec;98(6):1104–1108. doi: 10.1016/s0029-7844(01)01631-3. [DOI] [PubMed] [Google Scholar]
  13. Walmsley Sharon. Opt in or opt out: what is optimal for prenatal screening for HIV infection? CMAJ. 2003 Mar 18;168(6):707–708. [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES